1. Home
  2. LTRN vs ORBS Comparison

LTRN vs ORBS Comparison

Compare LTRN & ORBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LTRN
  • ORBS
  • Stock Information
  • Founded
  • LTRN 2013
  • ORBS 1966
  • Country
  • LTRN United States
  • ORBS United States
  • Employees
  • LTRN N/A
  • ORBS N/A
  • Industry
  • LTRN Biotechnology: Pharmaceutical Preparations
  • ORBS
  • Sector
  • LTRN Health Care
  • ORBS
  • Exchange
  • LTRN Nasdaq
  • ORBS Nasdaq
  • Market Cap
  • LTRN 49.9M
  • ORBS 47.6M
  • IPO Year
  • LTRN 2020
  • ORBS N/A
  • Fundamental
  • Price
  • LTRN $3.80
  • ORBS $2.41
  • Analyst Decision
  • LTRN Strong Buy
  • ORBS
  • Analyst Count
  • LTRN 1
  • ORBS 0
  • Target Price
  • LTRN $25.00
  • ORBS N/A
  • AVG Volume (30 Days)
  • LTRN 73.1K
  • ORBS 3.0M
  • Earning Date
  • LTRN 11-12-2025
  • ORBS 11-14-2025
  • Dividend Yield
  • LTRN N/A
  • ORBS N/A
  • EPS Growth
  • LTRN N/A
  • ORBS N/A
  • EPS
  • LTRN N/A
  • ORBS N/A
  • Revenue
  • LTRN N/A
  • ORBS $43,116,096.00
  • Revenue This Year
  • LTRN N/A
  • ORBS N/A
  • Revenue Next Year
  • LTRN N/A
  • ORBS N/A
  • P/E Ratio
  • LTRN N/A
  • ORBS N/A
  • Revenue Growth
  • LTRN N/A
  • ORBS 59.13
  • 52 Week Low
  • LTRN $2.55
  • ORBS $0.98
  • 52 Week High
  • LTRN $6.12
  • ORBS $83.12
  • Technical
  • Relative Strength Index (RSI)
  • LTRN 55.43
  • ORBS N/A
  • Support Level
  • LTRN $2.86
  • ORBS N/A
  • Resistance Level
  • LTRN $3.42
  • ORBS N/A
  • Average True Range (ATR)
  • LTRN 0.28
  • ORBS 0.00
  • MACD
  • LTRN 0.03
  • ORBS 0.00
  • Stochastic Oscillator
  • LTRN 99.80
  • ORBS 0.00

About LTRN Lantern Pharma Inc.

Lantern Pharma Inc is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, uses oncology-focused data points and advanced ML algorithms to solve billion-dollar, real-world problems in cancer drug development. The group's growing pipeline of precision therapies has been accelerated using AI and input from world-class scientific advisors and collaborators.

Share on Social Networks: